Literature DB >> 8702876

Mapping of Pax-2 transcription activation domains.

M S Lechner1, G R Dressler.   

Abstract

Pax genes encode transcription factors known to play crucial roles during the development of specific embryonic tissues. In humans and mice, several abnormalities have been linked to deficiencies in Pax gene dosage, indicating that normal development is particularly sensitive to the level of Pax gene expression. Despite these facts, relatively little is known about how these proteins act as transcriptional regulators. In this study we define the transactivation domains of murine Pax-2, an essential factor in kidney organogenesis. Within the COOH terminus of Pax-2, amino acids 279-373 are essential for transactivation. However, this region alone is insufficient for full transactivation when fused to the paired domain alone or to a heterologous DNA binding domain. Mutation or deletion of the conserved octapeptide sequence results in increased transactivation by Pax proteins. The octapeptide-mediated repression is also seen within a heterologous context using the GAL4 DNA binding domain. Thus transactivation by Pax-2 relies upon several regions within the COOH terminus and is down-modulated by the octapeptide element.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8702876     DOI: 10.1074/jbc.271.35.21088

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Transcriptional repression by Pax5 (BSAP) through interaction with corepressors of the Groucho family.

Authors:  D Eberhard; G Jiménez; B Heavey; M Busslinger
Journal:  EMBO J       Date:  2000-05-15       Impact factor: 11.598

2.  PTIP, a novel BRCT domain-containing protein interacts with Pax2 and is associated with active chromatin.

Authors:  M S Lechner; I Levitan; G R Dressler
Journal:  Nucleic Acids Res       Date:  2000-07-15       Impact factor: 16.971

3.  Comparative study of Pax2 expression in glial cells in the retina and optic nerve of birds and mammals.

Authors:  Jennifer Stanke; Holly E Moose; Heithem M El-Hodiri; Andy J Fischer
Journal:  J Comp Neurol       Date:  2010-06-15       Impact factor: 3.215

4.  Pax2 expression occurs in renal medullary epithelial cells in vivo and in cell culture, is osmoregulated, and promotes osmotic tolerance.

Authors:  Qi Cai; Natalia I Dmitrieva; Joan D Ferraris; Heddwen L Brooks; Bas W M van Balkom; Maurice Burg
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-27       Impact factor: 11.205

5.  Optimal activation of an endogenous gene by HOX11 requires the NH2-terminal 50 amino acids.

Authors:  N Masson; W K Greene; T H Rabbitts
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

6.  A Hox-Eya-Pax complex regulates early kidney developmental gene expression.

Authors:  Ke-Qin Gong; Alisha R Yallowitz; Hanshi Sun; Gregory R Dressler; Deneen M Wellik
Journal:  Mol Cell Biol       Date:  2007-09-04       Impact factor: 4.272

Review 7.  Patterning and early cell lineage decisions in the developing kidney: the role of Pax genes.

Authors:  Gregory R Dressler
Journal:  Pediatr Nephrol       Date:  2011-01-11       Impact factor: 3.714

Review 8.  Epigenetics in kidney development and renal disease.

Authors:  Gregory R Dressler; Sanjeevkumar R Patel
Journal:  Transl Res       Date:  2014-06-04       Impact factor: 7.012

9.  Mutations in PAX2 associate with adult-onset FSGS.

Authors:  Moumita Barua; Emilia Stellacci; Lorenzo Stella; Astrid Weins; Giulio Genovese; Valentina Muto; Viviana Caputo; Hakan R Toka; Victoria T Charoonratana; Marco Tartaglia; Martin R Pollak
Journal:  J Am Soc Nephrol       Date:  2014-03-27       Impact factor: 10.121

10.  Papillorenal syndrome-causing missense mutations in PAX2/Pax2 result in hypomorphic alleles in mouse and human.

Authors:  Ramakrishna P Alur; Camasamudram Vijayasarathy; Jacob D Brown; Mohit Mehtani; Ighovie F Onojafe; Yuri V Sergeev; Elangovan Boobalan; Marypat Jones; Ke Tang; Haiquan Liu; Chun-Hong Xia; Xiaohua Gong; Brian P Brooks
Journal:  PLoS Genet       Date:  2010-03-05       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.